{"body":"<p>In areas of very low transmission, it may be impossible to accrue the number of patients required for a TES. If the country has strengthened its surveillance systems for eliminating malaria, surveillance of drug efficacy can be integrated into the routine surveillance system. In some countries with very low transmission, however, the surveillance systems are not yet sufficiently strong for this to be feasible<\/p>&#13;\n","title":"4.4 Monitoring the efficacy of antimalarial drugs in settings with very low transmission","nid":630,"vid":3055,"created":1576661748,"changed":1582558499,"field_content_type":{"tid":2,"name":"Content","class":"content"},"field_operational_":[{"field_image":"","field_link":"","field_title":null}],"field_references":null,"field_tags":[{"tid":42,"name":"Drug efficacy & resistance"}]}